Navigation Links
Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry

RALEIGH, N.C., July 8 /PRNewswire/ -- Pharmaceutical Institute, a subsidiary of Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced the release of a revised edition of "Understanding Pharma", updated to reflect a dynamic market environment and offering key new insights on how pharmaceutical and biotechnology companies work.

The new edition of "Understanding Pharma" analyzes nine key functional areas within a typical company and explains how they work together to discover, develop, and commercialize drugs. This second edition represents a significant expansion of the original book including:

-- Over 40 additional pages

-- New chapter on Medical Affairs

-- New content related to the distinctive issues and requirements surrounding biopharmaceuticals

-- Significant updates to the Managed Markets and Trade and Distribution chapters

-- Revised data points throughout to maintain currency

In writing "Understanding Pharma", Campbell Alliance CEO John Campbell drew on nearly 20 years of experience in the pharmaceutical and biotechnology industries, including senior roles at GlaxoWellcome (now GlaxoSmithKline), prior to founding Campbell Alliance in 1997.

"From my experience, the most effective teams have a comprehensive cross-functional understanding of the industry, particularly in regard to how each functional area's work is integral to the success of the entire organization," stated Mr. Campbell. "Maintaining this mentality is essential to improving collaboration and efficiency throughout any organization."

"Understanding Pharma", originally published by Pharmaceutical Institute in 2005, was the first book to systematically explain how the typical pharmaceutical company operates, function by function. The book and nine-module e-course series have been incorporated into the professional development programs of numerous leading pharmaceutical and biotech companies, as well as curricula for students in many prestigious MBA programs who are preparing for careers in the industry. Thousands of copies of the first edition have been sold, and multiple printings have sold out.

"'Understanding Pharma' provides a practical perspective on the full range of functional areas within a pharmaceutical or biotech company, while showing how all of the parts of this complex enterprise work together and influence one another," said Dan Blue, Executive Director of Pharmaceutical Institute. "The book is designed to serve as an excellent resource for anyone working within or around the pharmaceutical industry, including industry veterans, newcomers, students, journalists, consultants, and scientists. It really offers a comprehensive overview of the industry as a whole and how these companies work."

Of the revised edition's 12 chapters, nine are devoted to individual functional areas: Discovery, Drug Development, Medical Affairs, Business Development, Marketing, Sales, Managed Markets, Manufacturing Operations, and Trade and Distribution. Each chapter describes the function's basic responsibilities and its importance to the larger organization; provides details on key tasks, processes, and activities; discusses how the function is typically organized; and describes any supporting functions normally associated with it.

For example,

-- "Discovery" covers milestones in the discovery process, as well as new discovery methods.

-- "Drug Development" charts the progression from preclinical through clinical development and FDA approval.

-- "Medical Affairs" provides details on effectively communicating the science behind innovative products.

-- "Business Development" explains the considerations and activities involved in the in-licensing of products to build a company's pipeline.

-- "Marketing" outlines this commercial function's role across the commercial life cycle, from pre-launch through patent expiration and beyond.

-- "Sales" describes how sales representatives are trained and compensated, how they prepare for and execute sales calls, the diverse ways a sales organization can be organized, and the purpose and process of prescriber segmentation.

-- "Managed Markets" provides an overview of payers, health plans, pharmacy benefit managers, hospitals and other healthcare providers, describing how pharma and biotech companies develop strategies to attain desired product positioning from the most important of these accounts.

-- "Manufacturing Operations" explains the complex, highly regulated processes involved in making a drug product for clinical trials and scaling it up for commercial use.

-- "Trade and Distribution" offers an overview of the journey that products take from manufacturing sites to the consumer.

Additional chapters in the book include

-- "Introduction to the Industry": Provides a historical overview of pharmaceutical innovation, dating back to the 1800s; compares traditional pharma companies with biotech companies; and examines the private and governmental regulatory framework circumscribing industry practices

-- "What Is a Drug?": Examines the definitions of drugs and biologics, as well as addressing key concepts such as active pharmaceutical ingredients, mechanism of action, pharmacokinetics, pharmacodynamics, drug categories, and indications

-- "Pharma and Biotech Customers": Profiles the three leading "demand drivers" in the industry-prescribers, payers and health plans, and patients

"Understanding Pharma, Second Edition", also contains a useful appendix on the make-up of the pharma industry's corporate infrastructure, including finance, human resources, information technology, and legal departments.

"Understanding Pharma, Second Edition", is a must-read for anyone in the pharma industry-those new to the industry, industry veterans, and those serving the industry. The book is available for $99.95 through Pharmaceutical Institute. For more information or to purchase the book, please visit .

About Pharmaceutical Institute

Pharmaceutical Institute, based in Raleigh, NC, is the leading provider of specialized knowledge for pharma and biotech professionals. The company offers clients comprehensive e-learning training solutions, including an extensive catalog of e-courses and custom course development services. Additionally, Pharmaceutical Institute has one of the largest online catalogs of industry-related books and syndicated market research reports from leading publishers. This extensive library, combined with a team of research professionals and librarians, provides clients with a convenient one-stop source for pharmaceutical and biotech market intelligence. Pharmaceutical Institute's clients include numerous leading pharmaceutical and biotech companies, as well as companies that support the industry.

Pharmaceutical Institute was created by Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries. Campbell Alliance provides resources and expertise to maximize Pharmaceutical Institute's effectiveness in providing research and educational services to its clientele.

For more information, please visit .

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, Parsippany, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit .

SOURCE Pharmaceutical Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Edison Pharmaceuticals Receives Commendation From the City of San Jose
2. Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poors Market Access Program
3. Transcept Pharmaceuticals Appoints Key Senior Executives
4. Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications
5. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
6. Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call
7. Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules
8. Alseres Pharmaceuticals, Inc. Raises $5 Million
9. Raptor Pharmaceuticals Closes $10 Million Private Placement
10. SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
11. VIA Pharmaceuticals Set to Join Russell Microcap Index
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont Pioneer and recently ... have entered into a multiyear collaboration to identify and characterize novel CRISPR-Cas nucleases. ... for gene editing across all applications. , Under the terms of the agreement, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality ... Several trends in analytical testing are being attributed to new regulatory requirements for ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
Breaking Biology Technology:
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
(Date:3/23/2017)... March 23, 2017 The report "Gesture Recognition and Touchless ... and Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is ... of 29.63% between 2017 and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):